RESOURCE GUIDE / 2009

Features

About Cancer: What is Cancer?Understanding cancer means knowing it's more than one disease 

About Cancer: Cancer TherapiesAn easy-to-understand explanation of the various types of cancer treatment 

About Cancer: Pathology & StagingHow much, what it looks like, and where it is guide diagnosis and treatment 

At Diagnosis: Dealing With EmotionsHow to recognize normal reactions at diagnosis and when you need help 

At Diagnosis: Special Issues by AgeWhether you're diagnosed in your 30s or your 60s, age impacts what you do next 

Before Treatment: Medical DecisionsSix steps for handling the stress of choosing treatment 

Before Treatment: Seeking a Second OpinionWhy and how to get another opinion about your diagnosis or treatment 

Before Treatment: Understanding Clinical TrialsWhat you need to know to decide if a clinical trial is right for you 

Before Treatment: Insurance IssuesStrategies to make sure you're getting the most out of your insurance plan 

During Treatment: Side Effects of TherapyToxic effects caused by treatment have their own management strategies

During Treatment: Nutrition FactsAnswers to important questions about nutrition and diet 

During Treatment: Financial MattersOrganization and help are crucial in managing your finances during treatment 

After Treatment: A Post-Treatment PrescriptionPatients are no longer on their own when treatment ends 

After Treatment: Exercise & RecoveryPhysical activity can help improve mental and physical functioning after cancer treatment 

After Treatment: Back to 'Normal'Strategies help patients adjust to life after treatment 

For the Caregiver: A New RoleNavigating the challenging territory of caregiving 

For the Caregiver: Taking Care of YourselfHow and why caregivers should care for themselves 

Cancer Genes

RELATED ARTICLES

Genetic testing is now available for dozens of hereditary cancer syndromes, most of which are caused by alterations in genes that suppress tumor growth.

To date, the most commonly requested test is for BRCA1 and BRCA2. Alterations in these two genes predispose individuals to breast, ovarian, and other cancers.

Although these mutations can affect people of any race or ethnicity, they are found more frequently in families of Ashkenazi Jewish descent. Among female carriers, BRCA alterations may confer a lifetime breast cancer risk of up to 85 percent (though new research suggests breast cancer risk varies among families and may only be as high as about 50 percent) and an ovarian cancer risk of up to 50 percent. Male carriers also have increased risk for breast, prostate, and other cancers.

Other frequently used genetic tests are for two colon cancer syndromes: hereditary nonpolyposis colon cancer (HNPCC) and familial adenomatous polyposis (FAP). Both syndromes are associated with a high risk for colon cancer (80 percent and virtually 100 percent, respectively) and other cancers.

Recently, several familial syndromes have been linked to kidney cancer. In von Hippel-Lindau disease, patients inherit a defect in a specific gene called the von Hippel-Lindau gene, though people without the inherited disease can also have problems with the VHL gene. The VHL gene is a tumor suppressor gene, so inactivation of the gene can cause up to 80 percent of all sporadic (non-hereditary) clear-cell renal cell carcinomas, the most common type of kidney cancer. These discoveries provided researchers with a specific target for developing therapies to treat kidney cancer.

For those who test positive for a genetic mutation, increased screening is needed. Some patients may also consider chemoprevention strategies to help lower their risk of second cancers or recurrence. In other cases, cancer may be prevented altogether using prophylactic (preventive) surgeries.

 

^ TOP OF PAGE